HCWB (HCW Biologics Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
HCW Biologics Inc. Common Stock (HCWB) is a publicly traded Healthcare sector company. As of May 21, 2026, HCWB trades at $2.05 with a market cap of $9.02M and a P/E ratio of -0.38. HCWB moved +133.49% today. Year to date, HCWB is +118.92%; over the trailing twelve months it is -73.53%. Its 52-week range spans $0.25 to $100.80. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces HCWB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns HCWB stock?
Hedge funds tracked by Rallies that own HCWB include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HCW Biologics Inc. Common Stock.
HCWB Key Metrics
Key financial metrics for HCWB
Metric
Value
Price
$2.05
Market Cap
$9.02M
P/E Ratio
-0.38
EPS
$-7.73
Dividend Yield
0.00%
52-Week High
$100.80
52-Week Low
$0.25
Volume
1.38M
Avg Volume
0
Revenue (TTM)
$6.55M
Net Income
$-2.29M
Gross Margin
99.89%
Top Hedge Funds Holding HCWB
Citadel Advisors holds 13.88K shares of HCWB, changed +34.05% as of Jun 30, 2024.
Two Sigma holds 12.08K shares of HCWB, changed -46.17% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own HCWB include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HCW Biologics Inc. Common Stock.
Does Rallies show 13F holders for HCWB?
Yes. Rallies tracks hedge fund and 13F ownership data for HCWB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HCWB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HCWB. It does not provide personalized investment advice.
